Hikma Sharpens Focus On COVID-19 Demand
Maintains Financial Guidance Amid Coronavirus Challenges And Uncertainty
Hikma says it is prioritizing the production and delivery of medicines that are in the highest demand amid the COVID-19 pandemic, as the firm has provided a trading update that maintains its sales forecasts in the face of “challenging market conditions” and uncertainty.
